-+ 0.00%
-+ 0.00%
-+ 0.00%
Indian pharmaceutical company Alembic Pharma's application for the marketing of binimetinib generic drugs was approved by the US Food and Drug Administration.
Share
Listen to the news
Indian pharmaceutical company Alembic Pharma's application for the marketing of binimetinib generic drugs was approved by the US Food and Drug Administration.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending